1. website-feature

      Patients deserve progress - a cure can't wait. Give today

National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow.
This means effecting change in the system at all levels.

Together, We Create Real Impact

5 FDA treatments approved 500k in research funded 3 Legislative wins in 2012

From the Blog

  1. August 25, 2015

    Brain Tumor Groups Come Together for New Imaging Effort

    nci-vol-1755-300

    When an athlete injures their knee, ankle, shoulder, etc. they will often need to go for an “MRI” to determine the extent of the damage done to the affected area. And in most cases the MRI will be able to diagnose the issues with relative ease, accuracy and expediency. Most Americans are familiar with MRIs […]

    Brain Tumor Groups Come Together for New Imaging Effort Read more | 
  2. August 20, 2015

    President Carter’s Diagnosis – Explaining Secondary (Metastatic) Brain Cancer

    nci-vol-1980-300

    Former President Jimmy Carter announced earlier today that he has been diagnosed with melanoma, the most serious form of skin cancer, which has spread to his brain. What does this mean? Is this the same as brain cancer? If not, what’s the difference? Cancer that begins in one spot of the body and then spreads […]

    President Carter’s Diagnosis – Explaining Secondary (Metastatic) Brain Cancer Read more | 
  3. August 20, 2015

    WEBINAR ALERT: Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Clinical Trials

    Webinar to Discuss New Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Neuro-Oncology Clinical Trials WHAT: Webinar led by international leaders of Brain Tumor Imaging Standardization Steering Committee will educate neuro-oncology and neuroimaging field on latest recommendations for MRI use in clinical studies WHEN: Tuesday, September 22, 11:00 AM – 12:00 PM (EST) […]

    Read more | 
More from the blog